Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)

Eisai Inc. · 2008
ClinicalTrials.gov · Datasets · License: Public Domain · 2008
Open Source ↗
gastroesophageal reflux disease (gerd), gerd, erosive gerd, erosive esophagitis, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 878032
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.